Search results
- 1.0512138 - ÚEB 2020 RIV FR eng J - Journal Article
Řezníčková, Eva - Gucký, Tomáš - Kováčová, Veronika - Ajani, Haresh - Jorda, Radek - Kryštof, Vladimír
Activity of 2,6,9-trisubstituted purines as potent PDGFRα kinase inhibitors with antileukaemic activity.
European Journal of Medicinal Chemistry. Roč. 182, Nov 15 (2019), č. článku 111663. ISSN 0223-5234. E-ISSN 1768-3254
Institutional support: RVO:61389030 ; RVO:61388963
Keywords : Acute myeloid leukaemia * Eosinophilic leukaemia * Kinase inhibitor * PDGFRα
OECD category: Hematology
Impact factor: 5.573, year: 2019
Method of publishing: Limited access
http://dx.doi.org/10.1016/j.ejmech.2019.111663
Permanent Link: http://hdl.handle.net/11104/0302348File Download Size Commentary Version Access 2019_Reznickova_European Journal of Medicinal Chemistry_111663.pdf 3 2.9 MB Other require - 2.0482957 - ÚEB 2018 RIV GB eng J - Journal Article
Malínková, Veronika - Řezníčková, Eva - Jorda, Radek - Gucký, T. - Kryštof, Vladimír
Trisubstituted purine inhibitors of PDGFR alpha and their antileukemic activity in the human eosinophilic cell line EOL-1.
Bioorganic & Medicinal Chemistry. Roč. 25, č. 24 (2017), s. 6523-6535. ISSN 0968-0896. E-ISSN 1464-3391
R&D Projects: GA MŠMT(CZ) LO1204
Institutional support: RVO:61389030
Keywords : dependent kinase inhibitors * src tyrosine kinase * 2,6,9-trisubstituted purines * therapeutic target * potent inhibitor * imatinib * leukemia * mutations * mutant * domain
OECD category: Hematology
Impact factor: 2.881, year: 2017
Permanent Link: http://hdl.handle.net/11104/0278331File Download Size Commentary Version Access 2017_Malinkova_Bioorganic & medicinal chemistry_6523.pdf 1 1.1 MB Other open-access - 3.0448652 - ÚEB 2016 RIV GB eng J - Journal Article
Malínková, Veronika - Vylíčil, Jakub - Kryštof, Vladimír
Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009-2014).
Expert Opinion on Therapeutic Patents. Roč. 25, č. 9 (2015), s. 953-970. ISSN 1354-3776. E-ISSN 1744-7674
R&D Projects: GA MŠMT(CZ) LO1204; GA MŠMT(CZ) ED3.1.00/14.0327; GA ČR(CZ) GA15-15264S
Institutional support: RVO:61389030
Keywords : cancer * CDK * cyclin
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.626, year: 2015
Permanent Link: http://hdl.handle.net/11104/0250287File Download Size Commentary Version Access 2015_Malinkova_EXPERT OPINION ON THERAPEUTIC PATENTS_953.pdf 3 699.3 KB Other open-access